Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9200
+0.0225 (2.51%)
At close: Oct 9, 2025, 4:00 PM EDT
0.9111
-0.0089 (-0.97%)
Pre-market: Oct 10, 2025, 7:42 AM EDT

Immunic Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Selling, General & Admin
19.3818.0116.0115.2613.310.33
Upgrade
Research & Development
85.8980.0583.2271.2661.1238.64
Upgrade
Other Operating Expenses
---32.9717.25-
Upgrade
Total Operating Expenses
105.2798.0599.22119.4991.6748.97
Upgrade
Operating Income
-105.27-98.05-99.22-119.49-91.67-48.97
Upgrade
Interest Income
1.633.393.081.040.070.06
Upgrade
Other Non-Operating Income (Expense)
1.83.752.54-1.961.354.9
Upgrade
Total Non-Operating Income (Expense)
3.437.145.61-0.921.414.95
Upgrade
Pretax Income
-101.84-90.92-93.61-120.41-90.25-44.02
Upgrade
Net Income
-101.84-100.51-93.61-120.41-92.95-44.02
Upgrade
Net Income to Common
-101.84-100.51-93.61-120.41-92.95-44.02
Upgrade
Shares Outstanding (Basic)
10910044322416
Upgrade
Shares Outstanding (Diluted)
10910044322416
Upgrade
Shares Change (YoY)
51.40%126.03%39.29%34.52%51.00%102.84%
Upgrade
EPS (Basic)
-0.94-1.00-2.11-3.78-3.93-2.81
Upgrade
EPS (Diluted)
-0.94-1.00-2.11-3.78-3.93-2.81
Upgrade
Free Cash Flow
-90.28-85.03-71.16-65.26-83.3-46.27
Upgrade
Free Cash Flow Per Share
-0.83-0.85-1.61-2.05-3.52-2.95
Upgrade
EBITDA
-105.1-97.92-99.11-119.41-91.58-48.93
Upgrade
EBIT
-105.27-98.05-99.22-119.49-91.67-48.97
Upgrade
Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q